When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.

Journals
More Content
PLOS BLOGS The Official PLOS Blog
Browse all PLOS Blogs
Browse all PLOS Blogs

Get to Know an Academic Editor: Yasuko Bando

PLOS Publishing
NOTE: This week PLOS is attending the European Society of Cardiology Congress in Paris, France. Stop by booth B550 to say hello. Dr. Bando is also attending ESC. Below is a brief, unedited interview with her. 

Q: Can you tell us a little about yourself?

I am senior lecturer & PI who works at Cardiology, Nagoya University Graduate School of Medicine, Japan. Targeting translational science in cardiovascular medicine, our team is enjoying and struggling with basic and clinical research.  Also, I am committee member of Japanese Circulation Society and International Society of Heart Research etc and dedicate myself to facilitating diversity and inclusion activities to share opportunity and social networking.

Q: How long have you been an academic editor for PLOS?

Six years, indeed. Time flies so fast!

Q: What is your specific area of study and why is it important?

My primary expertise is diabetic cardiomyopathy and diastolic heart failure at benchside. Recently, due to growing needs at bedside, we generate new team that focuses clinical research regarding onco-cardiology (cardio-oncology in US). Interestingly, I have noticed that my research experience on diabetic cardiomyopathy does seem to be applicable for those onco-cardiology.

Q: What first drew you into the field?

When I was medical student, I had started my scientific experience to explore the regulatory role of protein kinase C in calponin, a calcium-regulatory protein in smooth muscle contraction. That was pretty good start and this experience attracted me so much and I decide to dive deeply into basic science.

Q: Are there any trends in your field right now?

Metabolic remodeling and the role of mitochondria. Mitochondria is a mystery and gem of cardiovascular research.

Q: Why do you believe in Open Science?

Because open science contributes to enhance data reliability, feasibility, and popularity. Fortunately, the modern era of digital and network facilitates open science in easier and faster way.

Q: What are you most looking forward to at ESC this year?

Late breaking clinical science (Hot line). Plus, visit Foujita chapel at Reims, if I may have any chance to make small trip.

 

 

Back to top